Workflow
Globenewswire
icon
Search documents
Zevra Therapeutics to Present at the Citizens Life Sciences Conference
Globenewswire· 2026-02-25 12:30
CELEBRATION, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that members of Zevra’s executive leadership team will present at the Citizens Life Sciences Conference in Miami Beach, FL on Wednesday, March 11, 2026, at 9:00 a.m. ET. Additionally, management will be available for one-on-one meetings with registered conference attendees. A link ...
Rio Silver Inc. Announces $3.0 Million Non-Brokered Private Placement Led by Eric Sprott
Globenewswire· 2026-02-25 12:30
VANCOUVER, British Columbia, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Rio Silver Inc. (“Rio Silver” or the “Company”) (TSX-V: RYO | OTC: RYOOF) is pleased to announce a non-brokered private placement financing for gross proceeds of up to $3,000,000 (the “Offering”). Under the Offering, subject to regulatory approval, the Company intends to issue up to 8,571,429 units (the “Units”) at a price of $0.35 per Unit. Each Unit will consist of one common share of the Company and one-half (1/2) of one common share purchase ...
Medline Reports Fourth Quarter and Full Year 2025 Results
Globenewswire· 2026-02-25 12:30
Delivered strong full year 2025 resultsCompleted Initial Public OfferingIntroduced full year 2026 guidanceFourth quarter net sales of $7.8 billion, an increase of 14.8%Fourth quarter net income of $180 million, a decrease of 37.7%Fourth quarter Adjusted EBITDA1 of $805 million, approximately flatFull year net sales of $28.4 billion, an increase of 11.5%Full year net income of $1.2 billion, a decrease of 3.6%Full year Adjusted EBITDA1 of $3.5 billion, an increase of 3.2% NORTHFIELD, Ill., Feb. 25, 2026 (GLOB ...
Dyne Therapeutics to Participate in Upcoming Investor Conferences
Globenewswire· 2026-02-25 12:30
WALTHAM, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that management is scheduled to participate in the following upcoming investor conferences: TD Cowen 46th Annual Health Care Conference, fireside chat on Wednesday, March 4, 2026 at 11:50 a.m. ET in Boston, MA2026 Jefferies Biotech on the Beach Summit, hosting meetings o ...
Digital Realty Expands Innovation Lab Network to Singapore, Japan and London to Accelerate AI and Hybrid Cloud Implementation
Globenewswire· 2026-02-25 12:30
Core Insights - Digital Realty is expanding its Digital Realty Innovation Lab (DRIL) into Singapore, Japan, and London, marking its first foray into Asia Pacific and Europe after a successful launch in Northern Virginia [1][2] - The new DRIL locations will provide real-world testing environments for customers and partners to validate AI and hybrid cloud deployments, addressing the critical barrier of infrastructure readiness as AI adoption increases [2][7] Expansion Details - The Singapore DRIL will serve as a digital innovation hub, connecting local customers, partners, and research institutions with global technology providers [4] - The Japan DRIL will be located at the NRT12 data center in Greater Tokyo, featuring 20 racks with direct liquid cooling capabilities to support high-power-density workloads [5] - The UK DRIL in London will offer a dedicated environment for testing and validating AI and hybrid cloud deployments before full-scale implementation [5] Market Context - Singapore's digital economy, driven by AI adoption, accounts for 18.6% of total GDP, while Japan plans to invest over 10 trillion yen in semiconductor and AI sectors by 2030 [3] - The UK's AI sector is growing rapidly, with over 5,800 AI companies and sector revenue reaching £23.9 billion, generating £11.8 billion in GVA [3] Infrastructure Capabilities - The new DRIL locations will enable businesses to test performance, optimize configurations, and connect seamlessly to cloud and network providers via ServiceFabric®, Digital Realty's global interconnection platform [8] - The DRIL will leverage Digital Realty's Pervasive Datacenter Architecture (PDx®) methodology to facilitate the testing and validation of AI deployments in real-world conditions [9][10] Customer Engagement - Strong demand has been observed from customers and partners across Asia Pacific for dedicated environments to validate AI and hybrid cloud architectures [7] - The DRIL network supports a growing ecosystem of customers and partners, including major technology firms like AMD, Cisco, and Lenovo [10]
Avista Corp. Reports 2025 Financial Results, Initiates 2026 Utility Earnings Guidance
Globenewswire· 2026-02-25 12:05
SPOKANE, Wash., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Avista Corp. (NYSE: AVA) today reported net income based on GAAP of $193 million, or $2.38 per diluted share, compared to $180 million, or $2.29 per diluted share, in 2024. Non-GAAP utility earnings1 were $207 million, or $2.55 per diluted share, compared to $187 million, or $2.38 per diluted share in 2024. Our utility results were driven by strong operational execution, constructive regulatory outcomes, customer load growth, and disciplined cost management. ...
Celldex Completes Enrollment in Global Phase 3 Studies (EMBARQ-CSU1 and EMBARQ-CSU2) of Barzolvolimab in Chronic Spontaneous Urticaria
Globenewswire· 2026-02-25 12:01
Enrollment completed six months ahead of guidance, driven by significant unmet need for better treatments in CSUTopline data expected Q4 2026BLA submission planned for 2027 HAMPTON, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today the completion of enrollment in the Company’s global Phase 3 program of barzolvolimab in chronic spontaneous urticaria (CSU), which consists of two Phase 3 trials—EMBARQ-CSU1 and EMBARQ-CSU2. 1,939 patients were enrolled—the largest program conducted i ...
Aktsiaselts Infortar Investor Webinar introducing the results of the Q4 2025
Globenewswire· 2026-02-25 12:00
Infortar organized a webinar for investors today at 12:00 (EET) in Estonian and at 13:00 (EET) in English to introduce the fourth quarter 2025 results. The webinar was attended by Managing Director of Infortar Martti Talgre and Investor Relations Manager Kadri Laanvee. Webinar is available at followings links: - Estonian webinar- English webinar The webinar presentation is enclosed and also available at Infortar investor web https://infortar.ee/en/reports. Infortar operates in seven countries, the company's ...
EyePoint to Report Fourth Quarter and Full-Year 2025 Financial Results on March 4, 2026
Globenewswire· 2026-02-25 12:00
WATERTOWN, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced it will host a conference call and live webcast at 8:30 a.m. ET on Wednesday, March 4, 2026 to report its fourth quarter and full-year 2025 financial results and highlight recent corporate developments. To access the live conference call, please register using the audio ...
WeShop Helps Pet Lovers Turn Everyday Pet Spending into Ownership with Chewy and PetSmart
Globenewswire· 2026-02-25 12:00
NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- WeShop Holdings Limited (“WeShop” or the “Company”) (NASDAQ: WSHP), the world’s first community-owned social commerce platform, allows shoppers to earn equity while they shop at leading pet retailers including Chewy and PetSmart, giving the over 94 million pet owners in the U.S. even more ways to save while caring for their animals. Within the WeShop app, members can shop a curated selection of pet essentials, including premium pet food, treats, toys, grooming pro ...